Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q418274> ?p ?o }
Showing triples 1 to 58 of
58
with 100 triples per page.
- Q418274 subject Q6261856.
- Q418274 abstract "Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone - as marketed by Teva Pharmaceuticals) is an immunomodulator drug currently used to treat multiple sclerosis. It is a random polymer of four amino acids found in myelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine, and may work as a decoy for the immune system. Glatiramer acetate is approved by the Food and Drug Administration (FDA) for reducing the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability.Although the clinical definition of multiple sclerosis requires two or more episodes of symptoms and signs, glatiramer acetate is approved for treatment after single episodes. It is also used to treat relapsing-remitting multiple sclerosis. It is administered by subcutaneous injection.".
- Q418274 atcPrefix "L03".
- Q418274 atcSuffix "AX13".
- Q418274 casNumber "147245-92-9".
- Q418274 drugbank "DB05259".
- Q418274 fdaUniiCode "5M691HL4BO".
- Q418274 pubchem "3081884".
- Q418274 thumbnail Copaxone_Injection_Site_Reaction.JPG?width=300.
- Q418274 wikiPageExternalLink fdaDrugInfo.cfm?archiveid=837.
- Q418274 wikiPageExternalLink PrescribingInformation.pdf.
- Q418274 wikiPageExternalLink www.copaxone.com.
- Q418274 wikiPageWikiLink Q12156.
- Q418274 wikiPageWikiLink Q1427096.
- Q418274 wikiPageWikiLink Q145.
- Q418274 wikiPageWikiLink Q14692453.
- Q418274 wikiPageWikiLink Q14876140.
- Q418274 wikiPageWikiLink Q16.
- Q418274 wikiPageWikiLink Q161238.
- Q418274 wikiPageWikiLink Q178430.
- Q418274 wikiPageWikiLink Q181136.
- Q418274 wikiPageWikiLink Q188017.
- Q418274 wikiPageWikiLink Q2035485.
- Q418274 wikiPageWikiLink Q204711.
- Q418274 wikiPageWikiLink Q207350.
- Q418274 wikiPageWikiLink Q218642.
- Q418274 wikiPageWikiLink Q30.
- Q418274 wikiPageWikiLink Q3145229.
- Q418274 wikiPageWikiLink Q3500973.
- Q418274 wikiPageWikiLink Q4182.
- Q418274 wikiPageWikiLink Q432187.
- Q418274 wikiPageWikiLink Q458.
- Q418274 wikiPageWikiLink Q46210.
- Q418274 wikiPageWikiLink Q5092.
- Q418274 wikiPageWikiLink Q512627.
- Q418274 wikiPageWikiLink Q6261856.
- Q418274 wikiPageWikiLink Q6939135.
- Q418274 wikiPageWikiLink Q7200267.
- Q418274 wikiPageWikiLink Q801.
- Q418274 wikiPageWikiLink Q8066.
- Q418274 wikiPageWikiLink Q818574.
- Q418274 wikiPageWikiLink Q8277.
- Q418274 wikiPageWikiLink Q898750.
- Q418274 atcPrefix "L03".
- Q418274 atcSuffix "AX13".
- Q418274 casNumber "147245".
- Q418274 drugbank "DB05259".
- Q418274 pubchem "3081884".
- Q418274 unii "5".
- Q418274 type ChemicalSubstance.
- Q418274 type Drug.
- Q418274 type ChemicalObject.
- Q418274 type Thing.
- Q418274 type Q8386.
- Q418274 comment "Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone - as marketed by Teva Pharmaceuticals) is an immunomodulator drug currently used to treat multiple sclerosis. It is a random polymer of four amino acids found in myelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine, and may work as a decoy for the immune system.".
- Q418274 label "Glatiramer acetate".
- Q418274 depiction Copaxone_Injection_Site_Reaction.JPG.
- Q418274 homepage www.copaxone.com.